Por: The Hill Health April 18, 2023
A vaccine launched by Merck and Moderna was found to reduce the chances of skin cancer when used with the drug Keytruda, according to a new study released Monday. The new found that 79 percent of participants who received the vaccine and Keytruda stayed cancer-free for 18 months compared to just 62 percent of people who only received Merck’s Keytruda. The companies also said that the results of Phase Two showed mild side effects with the... + full article
ABC News USA Business December 14, 2022
Moderna’s stock soared Tuesday after the COVID-19 vaccine maker detailed progress in developing a preventive shot for a deadly form of skin cancer.The company said a possible melanoma vaccine it is studying with pharmaceutical giant Merck fared well in a small study of... + más
Merck, Moderna detail potential skin cancer vaccine progress | WPLG Local 10
Merck, Moderna detail potential skin cancer vaccine progress | Associated Press
ABC News USA Health December 14, 2022
CBS News USA Health December 14, 2022
Moderna's stock soared Tuesday after the maker detailed progress in developing a preventive shot for a deadly form of .The company said a possible vaccine it is studying with pharmaceutical giant Merck fared well in a small study of patients who had the cancer surgically... + más
ABC7 USA Health December 14, 2022
.The company said a possible melanoma vaccine it is studying with pharmaceutical giant Merck fared well in a small study of patients who had the cancer surgically removed.The drugmakers said a combination of the vaccine and Merck's immunotherapy Keytruda led to a... + más
WPLG Local 10 USA Health December 13, 2022
Merck, Moderna detail potential skin cancer vaccine progress | ABC News
Associated Press USA Health December 13, 2022
CNBC USA Health October 12, 2022
Pipettes are seen at the Moderna Therapeutics Inc. lab in Cambridge, Massachusetts, U.S., on Tuesday, Nov. 14, 2017. Moderna this week started testingAdam Glanzman Bloomberg Getty Images and will jointly develop and sell a cancer vaccine that is personalized for individual... + más
Moderna surges as Merck ramps up collaboration on cancer vaccine | The Boston Globe
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
About iurex | Privacy Policy | Disclaimer |